Skip to content
Use caution Drug recall · FDA · Published August 13, 2015

Bactroban Ointment Recall: Penicillin Contamination Risk

GlaxoSmithKline recalls Bactroban Ointment due to penicillin cross-contamination and foreign substances. Check your lot number C698039.

🇺🇸 FDA recall #D-1360-2015DrugBactroban ›
Take action

Contact the company

Recalling firmGlaxoSmithKline, LLC.1011 North Arendell Ave · Zebulon, NC 27597-1217
✎ GovInfoNow plain-language explainer

GlaxoSmithKline is recalling a specific batch of Bactroban Ointment because it may be contaminated with penicillin and other foreign substances introduced during manufacturing. This poses a risk to individuals who are allergic to penicillin, as exposure could trigger an adverse reaction. The recall affects 19,520 tubes distributed nationwide and in Puerto Rico. Read more at govinfonow.com/recall/43852-glaxosmithkline-llc-recalls-bactroban-ointment-mupirocin-calcium-2-22g-tube.

Source Summary by GovInfoNow · govinfonow.com/recall/43852-glaxosmithkline-llc-recalls-bactroban-ointment-mupirocin-calcium-2-22g-tube · Updated October 12, 2026 · FDA enforcement record: FDA #D-1360-2015

Cite this page

“Bactroban Ointment Recall: Penicillin Contamination Risk.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/43852-glaxosmithkline-llc-recalls-bactroban-ointment-mupirocin-calcium-2-22g-tube. Based on FDA recall #D-1360-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1360-2015%22&limit=1).

The FDA announced on August 13, 2015, that GlaxoSmithKline LLC voluntarily recalled Bactroban Ointment due to penicillin cross-contamination and foreign substances. Owners should contact the company for a refund.

How to tell if you have it

  • Brand: Bactroban
  • Product: Bactroban Ointment 2% Tube
  • NDC: 0029-1525-44
  • Lot #: C698039
  • Expiration: 03/2016

The hazard

The product was contaminated with penicillin and foreign substances during the manufacturing process, according to the FDA. The recall involves 19,520 tubes distributed nationwide and in Puerto Rico.

Context

GovInfoNow's records show GlaxoSmithKline LLC has had 11 other recalls since October 8, 2012. Other recent recalls of similar products include Tivicay PD Recall (May 17, 2024), GlaxoSmithKline ANORO ELLIPTA inhaler recall (December 12, 2023), and GlaxoSmithKline Tivicay Tablets recall (May 13, 2022). Other recent recalls of similar products include Dabur Med Pride Bacitracin Zinc Ointment Recall (June 2, 2026) and Golden State Baclofen Tablets Recall (November 26, 2025).

How to tell if you have this one

Check your tube for the following details: Brand Bactroban Ointment (mupirocin calcium), 2% concentration, 22g size. Look for NDC 0029-1525-44 and Lot Number C698039 with an expiration date of 03/2016.

  • Brand
    Bactroban
  • Category
    Drug
FDA recall event · 4 products

All 4 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide and Puerto Rico
Recall numberProduct, codes & lotsQuantity
D-1359-2015Bactroban (mupirocin calcium) Nasal Ointment, 2% 1g tube, Rx only, Manufactured by Glaxo Operations UK Ltd, Harmire Road, Barnard Castle, UK for GlaxoSmithKline PO Box 1217 Zebulon, NC 27597-1217. NDC 0029-1526-11; Lot #: C704202, Exp 11/2016; Lot #: C706532, Exp 12/2016; Lot #: C713177, Exp 1/2017; Lot #: C716567, Exp 2/2017, Lot #: C720097, C720098, Exp 3/2017, Expanded to include: C720096, Exp. 2/2017.88,489 tubes
D-1360-2015Bactroban Ointment (mupirocin calcium), 2% 22g tube ,Rx only, Manufactured by Glaxo Operations UK Ltd, Harmire Road, Barnard Castle, UK for GlaxoSmithKline PO Box 1217 Zebulon, NC 27597-1217. NDC 0029-1525-44; Lot #: C698039, Exp 03/201619,520 tubes
D-1361-2015Bactroban Cream (mupirocin calcium), 2%, a) 15g tube ( NDC 0029-1527-22), b) 30g tube (NDC 0029-1527-25), Rx only, Manufactured by Glaxo Operations UK Ltd, Harmire Road, Barnard Castle, UK for GlaxoSmithKline PO Box 1217 Zebulon, NC 27597-1217.; 15 g: Lot #: C695549, Exp 03/2016; 30 g: Lot #: C707836, Exp 7/2016; C718209, Exp 9/2016, Expanded to include: C707837, Exp. 07/2016, C718210, Exp. 09/2016.28,480 tubes of 15g, 12,234 tubes of 30g
D-1362-2015Mupirocin Calcium Cream, 2%, a) 15g tube (NDC 66993-942-15),b) 30g tube (NDC 66993-942-31), Rx only, Manufactured by Glaxo Operations UK Ltd, Harmire Road, Barnard Castle, UK for GlaxoSmithKline PO Box 1217 Zebulon, NC 27597-1217.; Lot #: C690076, C693373, Exp 2/2016; Lot #: C701378, C701376, Exp 4/2016; Lot #: C704164, Exp 5/2016; Lot #: C713687, Exp 8/2016; Lot #: C719467,C718203, Exp 9/2016; Lot #: C723641, Exp 10/2016; Lot #: C683884, Exp 12/2016; Lot #: C697653, Exp 3/2016; Lot #: C710477, Exp 7/2016; Expanded to include: C697654, Exp. 03/2016 (15 grams), C723642, Exp. 10/2016 (30 grams).166,070 of 15g tube, 112,720 of 30 g tube
Based on the official FDA remedy

What to do — step by step

  1. Check Your Product Details

    Verify if your Bactroban Ointment matches NDC 0029-1525-44 and Lot Number C698039.

  2. Contact Your Pharmacist or Doctor

    If you have the recalled product, consult your healthcare provider for guidance on what to do next.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 19 months after the firm started it.

1. Firm started the recall: Aug 13, 201512. FDA classified it Class II: Aug 25, 201523. Published in FDA’s Enforcement Report: Sep 2, 201534. FDA terminated the recall: Mar 21, 2017420152017
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1360-2015 (August 13, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1360-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA